UK calls its vaccination programme ‘huge success’, inoculates half of adult population

The UK government on Saturday said that its vaccination programme against coronavirus is a “huge success” as it announced that half of the adult population have now received first shot of the vaccine. The biggest vaccination drive in the history of Britain, which started in early December last year, was “making massive strides” following a record number of inoculations on Friday, nation’s Health Secretary Matt Hancock said, reports AFP.

Prime Minister Boris Johnson was among those to get a jab that day, receiving a first dose of AstraZeneca’s vaccine at the same London hospital where he fought for his life almost a year ago after contracting Covid-19.

Also Read | Chennai can be a stop in Boris Johnson’s India visit plan: Report

Britain has till now vaccinated nearly 27 million people and over 421,000 doses a day were administered in the week to Monday, state the latest health ministry statistics. 

However, the state-run National Health Service (NHS) in England warned this week in a letter to local vaccination centres that doses will be “significantly constrained” from March 29 for four weeks.

Also Read | UK Prime Minister Boris Johnson gets first AstraZeneca vaccine jab

The setback means the next phase of the inoculation campaign, covering people in their 40s, will have to be suspended until May, the letter said.

The government has insisted the change, caused by a supply shortfall from the Serum Institute of India, the world’s biggest vaccine maker, would not derail its plan to ease COVID-19 lockdowns in the coming months.

“I am absolutely delighted to tell you that we have now vaccinated half of all adults in the United Kingdom. It’s a huge success,” Hancock said in a video posted on Twitter.

“It’s so important, because this vaccine is our way out of this pandemic.”

Britain’s successful vaccination campaign contrasts with Europe, which has struggled with its own rollout and has been seeing a fresh surge in infections.

The AstraZeneca jab was suspended in several EU countries this month, pending a review by the European Medicines Agency (EMA) following isolated cases of blood clots and brain haemorrhages.

Also Read | US to reach 100 million vaccines, Europe resumes AstraZeneca jab

The EMA restated its approval for the vaccine on Thursday, as did the WHO and Britain’s own drugs regulator, leading some European countries to resume administering the vaccine.